Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy

Heart Rhythm

Volumn 6, Issue 3, 2009, Pages 305-310

  Borleffs, C Jan Willem ^a   Ypenburg, Claudia ^a   van Bommel, Rutger J ^a   Delgado, Victoria ^a   van Erven, Lieselot ^a   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atrial fibrillation; Biventricular pacing; Cardiac resynchronization therapy; Diastolic function; Echocardiography; Heart failure; Left ventricular function

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; QUALITY OF LIFE; RECURRENCE; VENTRICULAR FUNCTION, LEFT;

EID: 60949093262     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.12.017     Document Type: Article

References (35)

1. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
2. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
3. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
4. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. St John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
6. Yu C.M., Chau E., Sanderson J.E., et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105 (2002) 438-445
7. Yu C.M., Fang F., Zhang Q., et al. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol 50 (2007) 778-785
8. Adelstein E.C., and Saba S. Burden of atrial fibrillation after cardiac resynchronization therapy. Am J Cardiol 100 (2007) 268-272
9. Fung J.W., Yu C.M., Chan J.Y., et al. Effects of cardiac resynchronization therapy on incidence of atrial fibrillation in patients with poor left ventricular systolic function. Am J Cardiol 96 (2005) 728-731
10. Hoppe U.C., Casares J.M., Eiskjaer H., et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 114 (2006) 18-25
11. Hugl B., Bruns H.J., Unterberg-Buchwald C., et al. Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics. J Cardiovasc Electrophysiol 17 (2006) 813-817
12. Maisel W.H., and Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91 (2003) 2D-8D
13. Glotzer T.V., Hellkamp A.S., Zimmerman J., et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107 (2003) 1614-1619
14. Levy S., Camm A.J., Saksena S., et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 14 (2003) 443-445
15. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 (2002) 2145-2161
16. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 24 (2003) 13-15
17. Strickberger S.A., Conti J., Daoud E.G., et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 2146-2150
18. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
19. Lipkin D.P., Scriven A.J., Crake T., et al. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 292 (1986) 653-655
20. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
21. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
22. Wang Y., Moss J., and Thisted R. Predictors of body surface area. J Clin Anesth 4 (1992) 4-10
23. Garcia M.J., Thomas J.D., and Klein A.L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32 (1998) 865-875
24. Wang M., Yip G.W., Wang A.Y., et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41 (2003) 820-826
25. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 (2006) e84-e231
26. Bader H., Garrigue S., Lafitte S., et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 43 (2004) 248-256
27. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
28. Delnoy P.P., Ottervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 99 (2007) 1252-1257
29. Kies P., Leclercq C., Bleeker G.B., et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 92 (2006) 490-494
30. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 94 (2004) 1506-1509
31. Rienstra M., Smit M.D., Nieuwland W., et al. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator. Am Heart J 153 (2007) 120-126
32. Smit M.D., Van Dessel P.F., Rienstra M., et al. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients. Europace 8 (2006) 566-572
33. Nanthakumar K., Paquette M., Newman D., et al. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J 139 (2000) 797-803
34. Dini F.L., Cortigiani L., Baldini U., et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol 89 (2002) 518-523
35. Modena M.G., Muia N., Sgura F.A., et al. Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol 20 (1997) 553-560